Dr. Robert Hindes published numerous articles on infectious diseases like hepatitis B and C after completing a research fellowship at Harvard Medical School. The document discusses the co-infection of hepatitis C virus (HCV) and human immunodeficiency virus (HIV), noting that HCV is transmitted through contact with an infected person's blood, often from sharing needles, and this increases the risk of co-infection with HIV. It states that co-infected patients experience accelerated liver disease according to the National Institutes of Health.

1. The Co-Infection of HCV and HIV
By Robert Hindes MD

2. Introduction
• Following a research fellowship in infectious disease
at Harvard Medical School, Robert Hindes, MD,
went on to publish numerous articles on infectious
diseases, particularly hepatitis B and C viral
infections, in publications such as the New England
Journal of Medicine. Today, Robert Hindes, MD,
serves as the chief medical officer of Trek
Therapeutics, a benefit corporation he cofounded to
develop affordable treatments for the hepatitis C
virus and other infections.
Hepatitis C is a virus that causes severe damage to
the liver over time.

3. HCV and HIV
• The virus, commonly known as HCV, is transmitted
when an individual comes into contact with the
blood of an HCV patient, often through activities
such as sharing hypodermic needles or syringes. In
addition to passing on HCV, sharing needles
increases the odds that the individual will be co-
infected by the human immunodeficiency virus, or
HIV, as well as HCV.
According to the National Institutes of Health, co-
infected patients suffer from accelerated liver
disease.

4. Conclusion